Establishment Labs Holdings, Inc. (ESTA)
70.45
-2.13
(-2.93%)
USD |
NASDAQ |
Feb 11, 13:23
Establishment Labs Holdings EPS Diluted (Quarterly) : -0.3763 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.15M |
| Revenue (Quarterly) | 53.78M |
| Total Expenses (Quarterly) | 64.93M |
| Enterprise Value | 2.300B |
| Gross Profit Margin (Quarterly) | 70.09% |
| Profit Margin (Quarterly) | -20.72% |
| Earnings Yield | -4.04% |
| Normalized Earnings Yield | -4.040 |